Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 142 No. 2122 (2012)

Cardiac pre-competition screening in Swiss athletes

  • Christian Schmied
  • Sara Notz
  • Marco Cribari
  • Roman Gähwiler
  • Dagmar I Keller
  • Thomas F Lüscher
DOI
https://doi.org/10.4414/smw.2012.13575
Cite this as:
Swiss Med Wkly. 2012;142:w13575
Published
20.05.2012

Summary

AIM OF THE STUDY: In Switzerland, screening concepts for the prevention of sports-associated sudden cardiac death are still insufficiently established in the large group of competitive athletes who are not integrated in an Olympic- or other high-level squad. The aim of the present study was to objectively determine the current situation in this particular group of athletes concerning cardiac pre-competition screening and define specific features of an “ideal” Swiss screening concept. Based on these data, the feasibility and validity was tested by the implementation of an exemplary local screening programme.

METHODS: A standardised questionnaire was completed by 1,047 competitive athletes of different ages and gender. The individual, sports-specific profile of an athlete and furthermore, the personal attitude towards and the vision of a “perfect” cardiac screening were assessed. Based on the results, an exemplary local screening programme for competitive athletes was implemented at the “Academic Sports Association Zurich” (ASVZ) in Zurich, Switzerland and evaluated 1 year after its introduction.

RESULTS: Only 9% of the 1,047 interviewed competitive athletes (aged 13 to 64 years; median age 22 years, SD = 5.87) had previously undergone a cardiac screening. Only 47% of the interviewed competitive athletes expressed their interest to undergo a cardiac screening at all. Male and older athletes showed a significantly higher acceptance rate for the screening programme than women and younger athletes. All athletes accepted to bear the expenses for the baseline screening programme, adapted to international standards (minimal accepted fee of 60 Swiss Francs). Almost half of the athletes (49.2%) preferred easy accessibility to a sports cardiologist (max. distance of 10 kilometres). The exemplary local screening programme proved to be feasible and successful. However, only 30% of the 102 screened individuals were female and most of the athletes (80%) who made use of the screening had a specific concern or symptom (selection bias). A total of 5 athletes (4.9%) were, at least temporarily, declared as not eligible for competitive sports due to a relevant cardiac pathology.

CONCLUSION: The fact that only 9% of the interviewed competitive athletes had previously undergone cardiac screening is alarming, but underlines the necessity and urgency of implementing a cost-effective and adequate screening concept in the enormous group of competitive athletes who are not integrated in an Olympic- or other high-level squad. The need for a certain self-determination and personal responsibility of the athletes should be respected. Therefore, the screening should not be mandatory. However, adequate information about the issue is crucial for an informed decision.

References

  1. Corrado D, Basso C, Thiene G. Assay Sudden death in young athletes. Lancet. 2005;47–8.
  2. Maron BJ. Sudden death in young athletes. N Engl J Med., 2003;349:1064–75.
  3. Siscovick DS, Weiss NS, Fletcher RH, Lasky T. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med. 1984;311:874–7.
  4. Thompson PD, Funk EJ, Carleton RA, Sturner WQ. Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA. 1982;247:2535–8.
  5. Corrado D, Schmied C, Basso C, Borjesson M, Schiavon M, Pelliccia A, et al. Risk of sports: do we need a pre-participation screening for competitive and leisure athletes? Eur Heart J. 2011;32(8):934–44.
  6. Corrado D, Pelliccia A, Bjornstad HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26:516–24.
  7. Dvorak J, Grimm K, Schmied C, Junge A. Development and implementation of a standardized precompetition medical assessment of international elite football players. Clin J Sport Med. 2009;19(4):316–21.
  8. Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, PhysicalActivity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007;115:1643–455.
  9. Schmied C, Zerguini Y, Junge A, Tscholl P, Pelliccia A, Mayosi BM, Dvorak J; Cardiac findings in the precompetition medical assessment of football players participating in the 2009 African Under-17 Championships in Algeria, Br J Sports Med. 2009;43:716–21.
  10. Bille K, Fiquiras D, Schamasch P. Sudden cardiac death in athletes: the Lausanne recommendations. Eur J Cardiovasc Prev Rehabil. 2006;13:859–75.
  11. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296:1593–601.
  12. Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339:364–9.
  13. Maron BJ, Haas TS, Doerer JJ, Thompson PD, James HS. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol. 2009;104:276–80.
  14. Pelliccia A, Di Paolo FM, Corrado D, Buccolieri C, Quattrini FM, Pisicchio C, et al. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J. 2006;27:2196–200.
  15. Villiger B, Hintermann M, Goerre S, Kriemler S, Schmied C. Task Force “Prevention of Sudden Death in Elite Sport” SGSM/SSMS 2010; The sudden cardiac death of a young athlete: Recommendations for a sensible and effective preventive exam. Schweizerische Zeitschrift für «Sportmedizin und Sporttraumatologie» (2)/2011;59:108–9.
  16. Magazin des Akademischen Sportverbandes Zürich, “O2”, 29/2010: 4–5.
  17. Corrado D, Pelliccia A, Heidbuchel H, Sharma S, Link M, Basso C, et al. On behalf of the Sections of Sports Cardiology of the European Association of Cardiovascular Prevention and Rehabilitation; and the Working Group of Myocardial and Pericardial Disease of the European Society of Cardiology. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J. 2010;31(2):243–59.
  18. Etchells E, Bell C, Robb, K. Does this patient have an abnormal systolic murmur? JAMA. 1997;277(7):564.
  19. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47(7):476–85.
  20. Hoffmann A, Isler R. Kardiale Beurteilung der Sporttauglichkeit. Schweiz Med Forum. 2007;7(44):889–89.
  21. Maron BJ, Chaitman BR, Ackerman MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109(22):2807–16.
  22. http://www.freep.com/article/20091018/SPORTS23/91018016/3-runners-die-Detroit-marathon
  23. Keller, DI, Kardiale Screening-Untersuchungen beim Kompetitiv- und Gelegenheits-Athleten. Schweizerische Zeitschrift für Sportmedizin und Sporttraumatologie. 2011;59:79–82.
  24. Corrado D, Basso C, Schiavon M, Pelliccia A, Thiene G. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1981–9.
  25. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation. 2009;119:1085–92.
  26. Borjesson M, Urhausen A, Kouidi E, Dugmore D, Sharma S, Halle M, et al. Cardiovascular evaluation of middle-aged/senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010 Jun 19.
  27. Michaud K, Fellmann F, Abriel H, Beckmann JS, Mangin P, Elger BS. Molecular autopsy in sudden cardiac death and its implication for families: discussion of the practical, legal and ethical aspects of the multidisciplinary collaboration. Swiss Med Wkly. 2009;139(49-50):712–8.

Most read articles by the same author(s)